$ALNY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALNYLAM PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALNYLAM PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 58.18 | 700 | 40,724 | 12,588 | 13.3 K to 12.6 K (-5.27 %) |
Sep 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 57.39 | 5,550 | 318,515 | 13,288 | 18.8 K to 13.3 K (-29.46 %) |
Sep 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.30 | 6,250 | 58,125 | 18,838 | 12.6 K to 18.8 K (+49.65 %) |
Aug 16 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 0.95 | 60,000 | 57,000 | 45,263 | |
Aug 16 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 49.06 | 40,237 | 1,974,188 | 18,617 | 58.9 K to 18.6 K (-68.37 %) |
Aug 16 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 48.77 | 19,763 | 963,938 | 58,854 | 78.6 K to 58.9 K (-25.14 %) |
Aug 16 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 0.95 | 60,000 | 57,000 | 78,617 | 18.6 K to 78.6 K (+322.29 %) |
Jul 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance & Treas ... | Option Exercise | M | 31.39 | 14,200 | 445,738 | 0 | |
Jul 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance & Treas ... | Sell | S | 50.00 | 14,200 | 710,000 | 7,847 | 22 K to 7.8 K (-64.41 %) |
Jul 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance & Treas ... | Buy | M | 31.39 | 14,200 | 445,738 | 22,047 | 7.8 K to 22 K (+180.96 %) |
Jul 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 0.95 | 60,000 | 57,000 | 13,684 | |
Jul 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 37.11 | 60,000 | 2,226,822 | 18,617 | 78.6 K to 18.6 K (-76.32 %) |
Jul 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 0.95 | 60,000 | 57,000 | 78,617 | 18.6 K to 78.6 K (+322.29 %) |
Jul 02 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 22.75 | 15,000 | 341,250 | 0 | |
Jul 02 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 21.35 | 12,000 | 256,200 | 0 | |
Jul 02 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 32.00 | 15,000 | 480,000 | 7,847 | 22.8 K to 7.8 K (-65.65 %) |
Jul 02 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 22.75 | 15,000 | 341,250 | 22,847 | 7.8 K to 22.8 K (+191.16 %) |
Jul 02 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 32.00 | 12,000 | 384,000 | 7,847 | 19.8 K to 7.8 K (-60.46 %) |
Jul 02 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 21.35 | 12,000 | 256,200 | 19,847 | 7.8 K to 19.8 K (+152.92 %) |
Jun 10 2013 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | A | 30.09 | 15,000 | 451,350 | 15,000 | |
Jun 19 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 16.43 | 13,000 | 213,590 | 3,000 | |
Jun 19 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 10.98 | 6,250 | 68,625 | 12,500 | |
Jun 19 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 9.14 | 4,375 | 39,988 | 6,563 | |
Jun 19 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 29.93 | 6,250 | 187,079 | 7,847 | 14.1 K to 7.8 K (-44.34 %) |
Jun 19 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 10.98 | 6,250 | 68,625 | 14,097 | 7.8 K to 14.1 K (+79.65 %) |
Jun 19 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 29.93 | 4,375 | 130,956 | 7,847 | 12.2 K to 7.8 K (-35.80 %) |
Jun 19 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 9.14 | 4,375 | 39,988 | 12,222 | 7.8 K to 12.2 K (+55.75 %) |
Jun 19 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 29.93 | 13,000 | 389,125 | 7,847 | 20.8 K to 7.8 K (-62.36 %) |
Jun 19 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 16.43 | 13,000 | 213,590 | 20,847 | 7.8 K to 20.8 K (+165.67 %) |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.30 | 6,250 | 58,125 | 50,000 | |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.14 | 3,750 | 34,275 | 11,250 | |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 7.10 | 5,000 | 35,500 | 25,000 | |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 31.75 | 100 | 3,175 | 12,588 | 12.7 K to 12.6 K (-0.79 %) |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 31.07 | 4,900 | 152,249 | 12,688 | 17.6 K to 12.7 K (-27.86 %) |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 7.10 | 5,000 | 35,500 | 17,588 | 12.6 K to 17.6 K (+39.72 %) |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 31.07 | 6,250 | 194,196 | 12,588 | 18.8 K to 12.6 K (-33.18 %) |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.30 | 6,250 | 58,125 | 18,838 | 12.6 K to 18.8 K (+49.65 %) |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 31.07 | 3,750 | 116,517 | 12,588 | 16.3 K to 12.6 K (-22.95 %) |
Jun 13 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.14 | 3,750 | 34,275 | 16,338 | 12.6 K to 16.3 K (+29.79 %) |
Jun 10 2013 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 30.09 | 15,000 | 451,350 | 15,000 | |
Jun 10 2013 | ALNY | ALNYLAM PHARMACEUT ... | DZAU VICTOR J | Director | Option Exercise | A | 30.09 | 15,000 | 451,350 | 15,000 | |
Jun 10 2013 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | A | 30.09 | 15,000 | 451,350 | 15,000 | |
Jun 10 2013 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 30.09 | 25,000 | 752,250 | 25,000 | |
Jun 10 2013 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | A | 30.09 | 30,000 | 902,700 | 30,000 | |
Jun 10 2013 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 30.09 | 15,000 | 451,350 | 15,000 | |
Jun 10 2013 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | A | 30.09 | 15,000 | 451,350 | 15,000 | |
Jun 10 2013 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | A | 30.09 | 30,000 | 902,700 | 30,000 | |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP and Chief Busin ... | Option Exercise | M | 7.10 | 5,000 | 35,500 | 30,000 | |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP and Chief Busin ... | Sell | S | 30.00 | 5,000 | 150,000 | 11,681 | 16.7 K to 11.7 K (-29.97 %) |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP and Chief Busin ... | Buy | M | 7.10 | 5,000 | 35,500 | 16,681 | 11.7 K to 16.7 K (+42.80 %) |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 0.95 | 14,928 | 14,182 | 0 | |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 0.95 | 7,894 | 7,499 | 0 | |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Sell | S | 30.00 | 14,928 | 447,840 | 4,572 | 19.5 K to 4.6 K (-76.55 %) |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 0.95 | 14,928 | 14,182 | 19,500 | 4.6 K to 19.5 K (+326.51 %) |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Sell | S | 30.00 | 7,894 | 236,820 | 4,572 | 12.5 K to 4.6 K (-63.32 %) |
May 30 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 0.95 | 7,894 | 7,499 | 12,466 | 4.6 K to 12.5 K (+172.66 %) |
Mar 26 2013 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 0.95 | 26,000 | 24,700 | 0 | |
Mar 26 2013 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | M | 0.95 | 26,631 | 25,299 | 26,000 | |
Mar 26 2013 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 23.41 | 26,000 | 608,577 | 0 | 26 K to 0 (-100.00 %) |
Mar 26 2013 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 0.95 | 26,000 | 24,700 | 26,000 | 0 to 26 K |
Mar 26 2013 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Sell | S | 23.56 | 26,631 | 627,557 | 0 | 26.6 K to 0 (-100.00 %) |
Mar 26 2013 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Buy | M | 0.95 | 26,631 | 25,299 | 26,631 | 0 to 26.6 K |
Mar 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President & COO | Option Exercise | M | 0.95 | 24,058 | 22,855 | 0 | |
Mar 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President & COO | Sell | S | 25.00 | 24,058 | 601,450 | 4,572 | 28.6 K to 4.6 K (-84.03 %) |
Mar 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President & COO | Buy | M | 0.95 | 24,058 | 22,855 | 28,630 | 4.6 K to 28.6 K (+526.20 %) |
Mar 11 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.30 | 6,250 | 58,125 | 56,250 | |
Mar 11 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 24.55 | 6,250 | 153,415 | 12,588 | 18.8 K to 12.6 K (-33.18 %) |
Mar 11 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.30 | 6,250 | 58,125 | 18,838 | 12.6 K to 18.8 K (+49.65 %) |
Mar 11 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 0.95 | 24,000 | 22,800 | 24,058 | |
Mar 11 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Sell | S | 24.43 | 24,000 | 586,270 | 4,572 | 28.6 K to 4.6 K (-84.00 %) |
Mar 11 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 0.95 | 24,000 | 22,800 | 28,572 | 4.6 K to 28.6 K (+524.93 %) |
Feb 28 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 23.50 | 28,503 | 669,900 | 18,617 | 47.1 K to 18.6 K (-60.49 %) |
Feb 28 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 23.47 | 30,000 | 704,019 | 47,120 | 77.1 K to 47.1 K (-38.90 %) |
Feb 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 7.10 | 5,000 | 35,500 | 35,000 | |
Feb 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 25.00 | 5,000 | 125,000 | 11,681 | 16.7 K to 11.7 K (-29.97 %) |
Feb 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 7.10 | 5,000 | 35,500 | 16,681 | 11.7 K to 16.7 K (+42.80 %) |
Jan 24 2013 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | P | 20.13 | 4,967 | 99,986 | 14,269 | 9.3 K to 14.3 K (+53.40 %) |
Dec 21 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 18.66 | 10,000 | 186,600 | 10,000 | |
Dec 21 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | A | 18.66 | 50,000 | 933,000 | 50,000 | |
Dec 21 2012 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | A | 18.66 | 40,000 | 746,400 | 40,000 | |
Dec 21 2012 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | A | 18.66 | 100,000 | 1,866,000 | 100,000 | |
Dec 21 2012 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | A | 18.66 | 150,000 | 2,799,000 | 150,000 | |
Dec 21 2012 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 0.48 | 4,515 | 2,145 | 0 | |
Dec 21 2012 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 0.48 | 14,102 | 6,698 | 0 | |
Dec 21 2012 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 0.48 | 14,102 | 6,698 | 77,120 | 63 K to 77.1 K (+22.38 %) |
Dec 21 2012 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 0.48 | 4,515 | 2,145 | 63,018 | 58.5 K to 63 K (+7.72 %) |
Dec 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.14 | 3,750 | 34,275 | 15,000 | |
Dec 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.30 | 6,250 | 58,125 | 62,500 | |
Dec 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 7.10 | 4,777 | 33,917 | 30,000 | |
Dec 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 19.00 | 10,000 | 190,000 | 12,588 | 22.6 K to 12.6 K (-44.27 %) |
Dec 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.14 | 3,750 | 34,275 | 22,588 | 18.8 K to 22.6 K (+19.91 %) |
Dec 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.30 | 6,250 | 58,125 | 18,838 | 12.6 K to 18.8 K (+49.65 %) |
Dec 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 17.00 | 4,777 | 81,209 | 12,588 | 17.4 K to 12.6 K (-27.51 %) |
Dec 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 7.10 | 4,777 | 33,917 | 17,365 | 12.6 K to 17.4 K (+37.95 %) |
Dec 06 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 7.10 | 2,400 | 17,040 | 34,777 | |
Dec 06 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 17.04 | 2,400 | 40,896 | 12,588 | 15 K to 12.6 K (-16.01 %) |
Dec 06 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 7.10 | 2,400 | 17,040 | 14,988 | 12.6 K to 15 K (+19.07 %) |
Dec 04 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 7.10 | 2,823 | 20,043 | 37,177 | |
Dec 04 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 17.03 | 2,823 | 48,072 | 12,588 | 15.4 K to 12.6 K (-18.32 %) |
Dec 04 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 7.10 | 2,823 | 20,043 | 15,411 | 12.6 K to 15.4 K (+22.43 %) |
Dec 04 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 7.10 | 3,750 | 26,625 | 11,250 | |
Dec 04 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 16.93 | 3,750 | 63,472 | 7,847 | 11.6 K to 7.8 K (-32.34 %) |
Dec 04 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 7.10 | 3,750 | 26,625 | 11,597 | 7.8 K to 11.6 K (+47.79 %) |
Oct 11 2012 | ALNY | ALNYLAM PHARMACEUT ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Option Exercise | C | 0.00 | 6,150,500 | 0 | 0 | |
Oct 11 2012 | ALNY | ALNYLAM PHARMACEUT ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Buy | C | 0.00 | 6,150,500 | 0 | 6,150,500 | 0 to 6.2 M |
Sep 24 2012 | ALNY | ALNYLAM PHARMACEUT ... | NOVARTIS AG | 10% Owner | Sell | S | 19.42 | 1,551,896 | 30,137,820 | 4,051,002 | 5.6 M to 4.1 M (-27.70 %) |
Jul 31 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 10.98 | 6,250 | 68,625 | 18,750 | |
Jul 31 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 20.00 | 6,250 | 125,000 | 7,847 | 14.1 K to 7.8 K (-44.34 %) |
Jul 31 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 10.98 | 6,250 | 68,625 | 14,097 | 7.8 K to 14.1 K (+79.65 %) |
Sep 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.30 | 4,916 | 45,719 | 68,750 | |
Sep 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.30 | 1,334 | 12,406 | 73,666 | |
Sep 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 19.00 | 4,916 | 93,404 | 12,588 | 17.5 K to 12.6 K (-28.09 %) |
Sep 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.30 | 4,916 | 45,719 | 17,504 | 12.6 K to 17.5 K (+39.05 %) |
Sep 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 19.00 | 1,334 | 25,346 | 12,588 | 13.9 K to 12.6 K (-9.58 %) |
Sep 12 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.30 | 1,334 | 12,406 | 13,922 | 12.6 K to 13.9 K (+10.60 %) |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, Chief Medical ... | Option Exercise | M | 9.30 | 25,000 | 232,500 | 75,000 | |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, Chief Medical ... | Option Exercise | M | 9.14 | 11,250 | 102,825 | 18,750 | |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, Chief Medical ... | Sell | S | 19.00 | 11,250 | 213,750 | 12,588 | 23.8 K to 12.6 K (-47.19 %) |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, Chief Medical ... | Buy | M | 9.14 | 11,250 | 102,825 | 23,838 | 12.6 K to 23.8 K (+89.37 %) |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, Chief Medical ... | Sell | S | 19.00 | 25,000 | 475,000 | 12,588 | 37.6 K to 12.6 K (-66.51 %) |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, Chief Medical ... | Buy | M | 9.30 | 25,000 | 232,500 | 37,588 | 12.6 K to 37.6 K (+198.60 %) |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance & Treas ... | Option Exercise | M | 13.12 | 8,733 | 114,577 | 8,767 | |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance & Treas ... | Option Exercise | M | 9.14 | 6,562 | 59,977 | 10,938 | |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance & Treas ... | Sell | S | 18.00 | 6,562 | 118,116 | 7,847 | 14.4 K to 7.8 K (-45.54 %) |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance & Treas ... | Buy | M | 9.14 | 6,562 | 59,977 | 14,409 | 7.8 K to 14.4 K (+83.62 %) |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance & Treas ... | Sell | S | 19.00 | 8,733 | 165,927 | 7,847 | 16.6 K to 7.8 K (-52.67 %) |
Jul 18 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance & Treas ... | Buy | M | 13.12 | 8,733 | 114,577 | 16,580 | 7.8 K to 16.6 K (+111.29 %) |
Jun 25 2012 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 11.33 | 25,000 | 283,250 | 25,000 | |
Jun 25 2012 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | A | 11.33 | 30,000 | 339,900 | 30,000 | |
Jun 25 2012 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 11.33 | 15,000 | 169,950 | 15,000 | |
Jun 25 2012 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | A | 11.33 | 15,000 | 169,950 | 15,000 | |
Jun 25 2012 | ALNY | ALNYLAM PHARMACEUT ... | DZAU VICTOR J | Director | Option Exercise | A | 11.33 | 15,000 | 169,950 | 15,000 | |
Jun 25 2012 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 11.33 | 15,000 | 169,950 | 15,000 | |
Jun 25 2012 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | A | 11.33 | 15,000 | 169,950 | 15,000 | |
Feb 23 2012 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | P | 10.75 | 9,302 | 99,997 | 9,302 | 0 to 9.3 K |
Feb 23 2012 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | P | 10.75 | 93,023 | 999,997 | 252,111 | 159.1 K to 252.1 K (+58.47 %) |
Feb 23 2012 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Buy | P | 10.75 | 10,000 | 107,500 | 10,000 | 0 to 10 K |
Feb 23 2012 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | P | 10.75 | 930 | 9,998 | 11,681 | 10.8 K to 11.7 K (+8.65 %) |
Feb 23 2012 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | P | 10.75 | 5,581 | 59,996 | 58,503 | 52.9 K to 58.5 K (+10.55 %) |
Feb 23 2012 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | P | 10.75 | 1,860 | 19,995 | 4,572 | 2.7 K to 4.6 K (+68.58 %) |
Jan 25 2012 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, Chief Medical ... | Grant | A | 0.00 | 12,588 | 0 | 12,588 | 0 to 12.6 K |
Jan 25 2012 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Grant | A | 0.00 | 10,751 | 0 | 10,751 | 0 to 10.8 K |
Jan 25 2012 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Grant | A | 0.00 | 7,847 | 0 | 7,847 | 0 to 7.8 K |
Jan 11 2012 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | P | 8.80 | 567 | 4,992 | 2,712 | 2.1 K to 2.7 K (+26.43 %) |
Jan 11 2012 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | P | 8.81 | 1,134 | 9,995 | 52,922 | 51.8 K to 52.9 K (+2.19 %) |
Dec 14 2011 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | P | 7.15 | 699 | 4,995 | 2,145 | 1.4 K to 2.1 K (+48.34 %) |
Dec 14 2011 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | P | 7.15 | 1,397 | 9,995 | 51,788 | 50.4 K to 51.8 K (+2.77 %) |
Dec 02 2011 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 7.10 | 15,000 | 106,500 | 15,000 | |
Dec 02 2011 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | A | 7.10 | 40,000 | 284,000 | 40,000 | |
Dec 02 2011 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | SVP, Chief Medical ... | Option Exercise | A | 7.10 | 40,000 | 284,000 | 40,000 |